CN1225286C - 一组新型抗肿瘤基因治疗药物短干扰核糖核酸 - Google Patents
一组新型抗肿瘤基因治疗药物短干扰核糖核酸 Download PDFInfo
- Publication number
- CN1225286C CN1225286C CN 02159031 CN02159031A CN1225286C CN 1225286 C CN1225286 C CN 1225286C CN 02159031 CN02159031 CN 02159031 CN 02159031 A CN02159031 A CN 02159031A CN 1225286 C CN1225286 C CN 1225286C
- Authority
- CN
- China
- Prior art keywords
- sirna
- seq
- auc
- cell
- mdm2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02159031 CN1225286C (zh) | 2002-12-27 | 2002-12-27 | 一组新型抗肿瘤基因治疗药物短干扰核糖核酸 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02159031 CN1225286C (zh) | 2002-12-27 | 2002-12-27 | 一组新型抗肿瘤基因治疗药物短干扰核糖核酸 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1425466A CN1425466A (zh) | 2003-06-25 |
CN1225286C true CN1225286C (zh) | 2005-11-02 |
Family
ID=4753220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02159031 Expired - Fee Related CN1225286C (zh) | 2002-12-27 | 2002-12-27 | 一组新型抗肿瘤基因治疗药物短干扰核糖核酸 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1225286C (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100352922C (zh) * | 2003-08-07 | 2007-12-05 | 徐根兴 | 抑制人VEGF基因的表达的siRNA和表达载体及其在制药中的应用 |
CN100368423C (zh) * | 2003-11-21 | 2008-02-13 | 杭州新瑞佳生物医药技术开发有限公司 | 有效杀伤肿瘤细胞的针对PLK1 mRNA的小干扰核糖核酸分子(SiRNA)、其混合物及用途 |
CN1704123B (zh) * | 2004-06-01 | 2010-06-02 | 广州拓谱基因技术有限公司 | 用于体内预防或治疗呼吸系统疾病的小干扰rna制剂及其筛选方法 |
CN1313159C (zh) * | 2005-06-03 | 2007-05-02 | 陈志南 | HAb18G/CD147分子小片段干涉RNA药物及其用途 |
CN100374573C (zh) * | 2006-04-14 | 2008-03-12 | 中国医学科学院医药生物技术研究所 | 一种可稳定表达VEGF shRNA的载体pCD-VEGF |
CN101591655B (zh) * | 2009-06-01 | 2011-01-19 | 中山大学中山眼科中心 | 一种特异性阻断PKCα信号传递的siRNA及其应用 |
CN101921292B (zh) * | 2010-06-22 | 2013-11-13 | 中国医学科学院医药生物技术研究所 | 一种新型siRNA化学修饰单体及其制备方法和用途 |
CN103417988B (zh) * | 2013-07-20 | 2016-04-20 | 浙江大学 | Cdk2基因在制备白血病诱导分化治疗药物中的应用 |
CN107541513B (zh) * | 2016-06-28 | 2020-11-17 | 深圳宾德生物技术有限公司 | 用于沉默cd317的小分子干扰rna、重组载体、药物及其应用 |
-
2002
- 2002-12-27 CN CN 02159031 patent/CN1225286C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1425466A (zh) | 2003-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wu et al. | 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity | |
CN107454843B (zh) | 包含微小核糖核酸作为活性成分的用于治疗癌症的药物组合物 | |
US9820987B2 (en) | Modulator compounds of drug resistance in epithelial tumor cells | |
Chen et al. | miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans | |
CN107108686A (zh) | 用于恶性肿瘤的rna干扰组合物和方法 | |
EP2374884A2 (en) | Human miRNAs isolated from mesenchymal stem cells | |
CN1225286C (zh) | 一组新型抗肿瘤基因治疗药物短干扰核糖核酸 | |
Wang et al. | Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner | |
JPWO2008084319A1 (ja) | 新規核酸 | |
EP3604269A1 (en) | Application of compound or traditional chinese medicine extract in preparation of nucleic acid delivery agent and related products thereof | |
CN104774929A (zh) | miR-455-3p在食管鳞状细胞癌中的诊断、治疗和预后的应用 | |
Kadekar et al. | Synthetic design of asymmetric miRNA with an engineered 3′ overhang to improve strand selection | |
Yokomakura et al. | Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma | |
CN110904107B (zh) | 人tmeff1基因的用途及相关产品 | |
CN110283820B (zh) | 抑制细粒棘球蚴原头节dna氧化损伤修复基因表达的干扰rna及其应用 | |
CN112608998A (zh) | 人mt-nd1的用途及相关产品 | |
CN106215189A (zh) | 人微RNA miR‑185在制备细胞生长和/或衰老调控剂中的应用 | |
CN108096580B (zh) | 一种抑制神经母细胞瘤sh-sy5y的靶点及其应用 | |
CN1247608C (zh) | 一种新型乳腺癌基因治疗药物hdm2-siRNA | |
Stedt et al. | Specific inhibition of SRC kinase impairs malignant glioma growth in vitro and in vivo | |
CN105561344B (zh) | 一种RNAi技术联合小剂量ALA诱导肿瘤细胞原卟啉IX积聚的方法 | |
CN110938630B (zh) | 人b3gnt5基因的用途及相关产品 | |
CN101787368B (zh) | 抑制人Z38基因表达的siRNA及其在制备抗乳腺肿瘤药物中的应用 | |
KR101862247B1 (ko) | serpinb5에 대한 약물반응성을 가지는 마이크로 RNA를 함유하는 암치료용 의약조성물 및 이의 적용 | |
JP4911501B2 (ja) | 新規遺伝子発現抑制剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Jiangsu Huililong Plastic Industry Group Co., Ltd. Assignor: Biomedical Technology Inst., Chinese Academy of Medical Sciences Contract fulfillment period: 2009.2.10 to 2019.2.10 contract change Contract record no.: 2009320000447 Denomination of invention: Short interference ribonucleic acid as novel anti-tumor gene therapeutic medicine Granted publication date: 20051102 License type: exclusive license Record date: 2009.3.19 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.2.10 TO 2019.2.10; CHANGE OF CONTRACT Name of requester: JIANGSU HUILILONG PLASTIC INDUSTRY GROUP CO.,LTD. Effective date: 20090319 |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |